Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 329-337

  Paradela, Alberto ^a   Alvarez, Iñaki ^a   García Peydró, Marina ^a   Sesma, Laura ^a   Ramos, Manuel ^a   Vázquez, Jesús ^a   López De Castro, José A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA B27 ANTIGEN;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; T LYMPHOCYTE;

EID: 0033961477     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.329     Document Type: Article

References (40)

1. Deng, Y., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507.
2. Rock, K. L., and A. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:739.
3. Serwold, T., and N. Shastri. 1999. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells. J. Immunol. 162:4712.
4. Geier, E., G. Pfeifer, M. Wilm, M. Lucchiari-Hartz, W. Baumeister, K. Eichmann, and G. Niedermann. 1999. A giant protease with potential to substitute for some functions of the proteasome. Science 283:978.
5. Snyder, H. L., J. W. Yewdell, and J. R. Bennink. 1994. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:2389.
6. Roelse, J., M. Gromme, F. Momburg, G. Hammerling, and J. Neefjes. 1994. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180:1591
7. Elliott, T., A. Willis, V. Cerundolo, and A. Townsend. 1995. Processing of major histocompalibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1481.
8. Hughes, E. A., B. Ortmann, M. Surman, and P. Cresswell. 1996. The protease inhibitor. N-acetyl-L-leucyl-L-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum. J. Exp. Med. 183:1569.
9. Craiu, A., T. Akopian, A. Goldberg, and K. L. Rock. 1997. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl. Acad. Sci. USA 94:10850.
10. Beninga, J., K. L. Rock, and A. L. Goldberg. 1998. Interferon-gamma can stimulate post-proteasomal trimming of the N-terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem. 273:18734.
11. Gil-Torregrosa, B. C., A. R. Castano, and M. Del Val. 1998. Major histocompalibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin. J. Exp. Med. 188:1105.
12. Cerundolo, V., J. Alexander, K. Anderson, C. Lamb, P. Cresswell, A. McMichael, F. Gotch, and A. Townsend. 1990. Presentation of viral antigen controlled by a gene in the major histocompatibilily complex. Nature 345:449.
13. de la Salle, H., D. Hanau, D. Fricker, A. Urlacher, A. Kelly, J. Salamero, S. H. Powis, L. Donato, H. Bausinger, and M. Laforet. 1994. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265:237.
14. Uebel, S., W. Kraas, S. Kienle, K. H. Wiesmuller, G. Jung, and R. Tampe. 1997. Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries. Proc. Natl. Acad. Sci. USA 94:8976.
15. Daniel, S., V. Brusic, S. Caillat-Zucman, N. Petrovsky, L. Harrison, D. Riganelli, F. Sinigaglia, F. Gallazzi, J. Hammer, and P. M. Van Endert. 1998. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA elass I molecules. J. Immunol. 161:617.
16. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323.
17. Van Endert, P. M. 1999. Genes regulating MHC class I processing of antigen. Curr. Opin. Immunol. 11:82.
18. Peh, C. A., S. R. Burrows, M. Barnden, R. Khanna, P. Cresswell, D. J. Moss, and J. McCluskey. 1998. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 8:531.
19. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587.
20. Paradela, A., M. Garcia-Peydro, J. Vazquez, D. Rognan, and J. A. Lopez de Castro. 1998. The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity. J. Immunol. 161:5481.
21. Lopez, D., R. Garcia Hoyo, and J. A. Lopez de Castro. 1994. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes: implications for HLA-B27 association to spondyloarthropathy. J. Immunol. 152:5557.
22. Ljunggren, H. G., and K. Karre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162: 1745.
23. Townsend, A., C. Ohlen, J. Bastin, H. G. Ljunggren, L. Foster, and K. Karre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443.
24. Barnstable, C. J., W. F. Bodmer, G, Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools tor genetic analysis. Cell 14:9
25. Galocha, B., J. R. Lamas, J. A. Villadangos, J. P. Albar, and J. A. Lopez de Castro. 1996. Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism. Tissue Antigens 48:509.
26. Ellis, S. A., C. Taylor, and A. McMichael. 1982. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum. Immunol. 5:-49.
27. Brooks, J. M., R. A. Colbert, J. P. Mear, A. M. Leese, and A. B. Rickinson. 1998. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex. J. Immunol. 161:5252.
28. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Golderg. 1994, Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761.
29. Lee, D. H., and A. L. Goldberg. 1998. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8:397.
30. Craiu, A., M. Gaczynska, T. Akopian, C. F. Gramm, G. Fenteany, A. L. Goldberg, and K. L. Rock. 1997. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular proltin degradation and major histocompatibilily complex class I antigen presentation. J. Biol. Chem. 272:13437.
31. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726.
32. Ostrowska, H., C. Wojcik, S. Omura, and K. Worowski. 1997. Lactacystin, a specific inhibitor of ihe proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme. Biochem. Biophys. Res. Commun. 234:729.
33. Arribas, J. P. Arizti, and J. G. Castano. 1994. Antibodies against the C2 COOH terminal region discriminate the active and latent forms of the multicatalytic proteinase complex. J. Biol. Chem. 269:12858.
34. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
35. Rotzschke, O., K. Falk, S. Stevanovic, V. Gnau, G. Jung, and H. G. Rammensee. 1994. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 39:74.
36. Lamas, J. R., A. Paradela, F. Roncal, and J. A. Lopez de Castro 1999. Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis. Arthritis Rheum. 42:1975
37. Luckey. C. J., G. M. King, J. A. Marto, S. Venketeswaran, B. F. Maier, V. L. Crotzer, T. A. Colella. J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 1998. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J. Immunol. 161:112.
38. Chicz, R, M., R. G. Urban, W. S. Lane, J. C. Gorga, L. J. Stern, D. A. Vignali. and J. L. Strominger. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764.
39. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles, J. Exp. Med. 178:27.
40. Rammensee, H. G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.